LKC Technologies’ Portable RETeval™ Electrodiagnostic Device and Sensor Strips Earn Two United States Patents
Comprehensive electrophysiology system transforms eye care, enabling ophthalmologists and optometrists to conduct tests to assess…
2018 Degirmenci. Role of a mydriasis-free, full-field flicker ERG device…
The purpose of this study is to accelerate the development of new therapies, an inherited retinal degeneration model in a…
Easy and Effective Functional Test for Pediatric Ophthalmology Assessment with RETeval Complete™ Touted by Early Adopters
GAITHERSBURG, Md., March 28, 2016 – Jim Datovech, President of LKC Technologies, Inc. said, “We are learning from a number of…
RETeval™ Device Broadens Ophthalmologists’ Access to Functional Retinal Testing
LAS VEGAS, Nov. 13, 2015 — A low cost, handheld visual electrodiagnostic device cleared by the FDA last spring is now available…
RETeval™ Expands Presence at ARVO to Include Testing for Acquired and Inherited Diseases of the Retina
GAITHERSBURG, Md., April 22, 2015 – RETeval – DR™, a Welch Allyn device manufactured by LKC Technologies, Inc., is exclusively available outside…
Welch Allyn and LKC Technologies announce an exclusive distribution agreement for RETeval DR visual electrodiagnostic system
Exclusive Distribution Agreement Announced Welch Allyn and LKC Technologies announce an exclusive distribution agreement for RETeval DR visual electrodiagnostic system…
Promise of Faster, More Accessible Schizophrenia Diagnosis
A recent study shows promise of faster, more accessible schizophrenia diagnosis with the hand-held, portable, RETeval device.
LKC Technologies’ Clinical Trial Validates Cost-Effective Alternative to Gold Standard in Diabetic Retinopathy Screening
GAITHERSBURG, Maryland, Sept. 4, 2014 /PRNewswire/ — The EURETINA/ESCRS joint congress scheduled for 12-16 September is the setting for April Maa, MD, Primary…
LKC Technologies’ RETeval™ Completes Clinical Trial, Gains Capability
GAITHERSBURG, Md., April 28, 2014 – A rigorous multi-center clinical trial has completed testing over 400 diabetic patients to evaluate the effectiveness of…
LKC Technologies’ RETeval™ Undergoing Rigorous Clinical Trials
GAITHERSBURG, MD, January 21, 2014 – RETeval™ is a handheld DR screening device that enables virtually any health care provider to screen for…
Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to